GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » QUIA PHARMA AB (OSTO:QUIA) » Definitions » YoY EBITDA Growth

QUIA PHARMA AB (OSTO:QUIA) YoY EBITDA Growth : 80.00% (As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is QUIA PHARMA AB YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. QUIA PHARMA AB's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 80.00%.

QUIA PHARMA AB's EBITDA per Share for the six months ended in Dec. 2024 was kr-0.00.


QUIA PHARMA AB YoY EBITDA Growth Historical Data

The historical data trend for QUIA PHARMA AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QUIA PHARMA AB YoY EBITDA Growth Chart

QUIA PHARMA AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -20.75 57.18 99.42 66.04 55.56

QUIA PHARMA AB Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 99.59 82.61 54.55 -25.00 80.00

QUIA PHARMA AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

QUIA PHARMA AB's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(-0.008--0.018)/ | -0.018 |
=55.56 %

QUIA PHARMA AB's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(-0.002--0.01)/ | -0.01 |
=80.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


QUIA PHARMA AB YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of QUIA PHARMA AB's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


QUIA PHARMA AB Business Description

Traded in Other Exchanges
Address
Virdings Alle 32 B, Uppsala, SWE, 754 50
QUIA PHARMA AB is a development company for pharmaceuticals based on a patented drug delivery platform, Uni-Qleaver. The company develops improved and patentable forms of drugs under development or already approved by pharmaceutical authorities. These refined and enhanced forms of medicine are based on the Company's exceptional and patented technology platform. In addition to this, the Company offers multinational sales of omega-3, astaxin and collagen through Amazon.

QUIA PHARMA AB Headlines

No Headlines